Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new review in the Cochrane Database of Systematic Reviews has found.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗